These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 29298003)

  • 1. [Correlation Between Emotional-Affective Disorders and Gut Microbiota Composition in Patients with Parkinson’s Disease].
    Alifirova VM; Zhukova NG; Zhukova IA; Mironova YS; Petrov VA; Izhboldina OP; Titova MA; Latypova AV; Nikitina MA; Dorofeeva YB; Saltykova IV; Tyakht AV; Kostryukova ES; Sazonov AE
    Vestn Ross Akad Med Nauk; 2016; 71(6):427-35. PubMed ID: 29298003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural changes of gut microbiota in Parkinson's disease and its correlation with clinical features.
    Li W; Wu X; Hu X; Wang T; Liang S; Duan Y; Jin F; Qin B
    Sci China Life Sci; 2017 Nov; 60(11):1223-1233. PubMed ID: 28536926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variations in gut microbiota and fecal metabolic phenotype associated with depression by 16S rRNA gene sequencing and LC/MS-based metabolomics.
    Yu M; Jia H; Zhou C; Yang Y; Zhao Y; Yang M; Zou Z
    J Pharm Biomed Anal; 2017 May; 138():231-239. PubMed ID: 28219800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiota in patients with Parkinson's disease in southern China.
    Lin A; Zheng W; He Y; Tang W; Wei X; He R; Huang W; Su Y; Huang Y; Zhou H; Xie H
    Parkinsonism Relat Disord; 2018 Aug; 53():82-88. PubMed ID: 29776865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Gut Microbiota in Patients with Parkinson's Disease.
    Petrov VA; Saltykova IV; Zhukova IA; Alifirova VM; Zhukova NG; Dorofeeva YB; Tyakht AV; Kovarsky BA; Alekseev DG; Kostryukova ES; Mironova YS; Izhboldina OP; Nikitina MA; Perevozchikova TV; Fait EA; Babenko VV; Vakhitova MT; Govorun VM; Sazonov AE
    Bull Exp Biol Med; 2017 Apr; 162(6):734-737. PubMed ID: 28429209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut Microbiota is Altered in Patients with Alzheimer's Disease.
    Zhuang ZQ; Shen LL; Li WW; Fu X; Zeng F; Gui L; Lü Y; Cai M; Zhu C; Tan YL; Zheng P; Li HY; Zhu J; Zhou HD; Bu XL; Wang YJ
    J Alzheimers Dis; 2018; 63(4):1337-1346. PubMed ID: 29758946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anxiety rating scales in Parkinson's disease: a validation study of the Hamilton anxiety rating scale, the Beck anxiety inventory, and the hospital anxiety and depression scale.
    Leentjens AF; Dujardin K; Marsh L; Richard IH; Starkstein SE; Martinez-Martin P
    Mov Disord; 2011 Feb; 26(3):407-15. PubMed ID: 21384425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain-gut-microbiota axis in Parkinson's disease.
    Mulak A; Bonaz B
    World J Gastroenterol; 2015 Oct; 21(37):10609-20. PubMed ID: 26457021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteration of the fecal microbiota in North-Eastern Han Chinese population with sporadic Parkinson's disease.
    Li F; Wang P; Chen Z; Sui X; Xie X; Zhang J
    Neurosci Lett; 2019 Aug; 707():134297. PubMed ID: 31200089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered gut microbiota in Parkinson's disease patients/healthy spouses and its association with clinical features.
    Zhang F; Yue L; Fang X; Wang G; Li C; Sun X; Jia X; Yang J; Song J; Zhang Y; Guo C; Ma G; Sang M; Chen F; Wang P
    Parkinsonism Relat Disord; 2020 Dec; 81():84-88. PubMed ID: 33099131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls.
    Unger MM; Spiegel J; Dillmann KU; Grundmann D; Philippeit H; Bürmann J; Faßbender K; Schwiertz A; Schäfer KH
    Parkinsonism Relat Disord; 2016 Nov; 32():66-72. PubMed ID: 27591074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for anxiety symptoms in Parkinson disease: a cross-sectional study.
    Stefanova E; Ziropadja L; Petrović M; Stojković T; Kostić V
    J Geriatr Psychiatry Neurol; 2013 Mar; 26(1):34-40. PubMed ID: 23407399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anxiety in Parkinson's disease: Symptom dimensions and overlap with depression and autonomic failure.
    Rutten S; Ghielen I; Vriend C; Hoogendoorn AW; Berendse HW; Leentjens AF; van der Werf YD; Smit JH; van den Heuvel OA
    Parkinsonism Relat Disord; 2015 Mar; 21(3):189-93. PubMed ID: 25557888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson's disease.
    Lin CH; Chen CC; Chiang HL; Liou JM; Chang CM; Lu TP; Chuang EY; Tai YC; Cheng C; Lin HY; Wu MS
    J Neuroinflammation; 2019 Jun; 16(1):129. PubMed ID: 31248424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anxious and depressive symptoms in Parkinson's disease: the French cross-sectionnal DoPaMiP study.
    Nègre-Pagès L; Grandjean H; Lapeyre-Mestre M; Montastruc JL; Fourrier A; Lépine JP; Rascol O;
    Mov Disord; 2010 Jan; 25(2):157-66. PubMed ID: 19950403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suitability of the Depression, Anxiety, and Stress Scale in Parkinson's Disease.
    Johnson AR; Lawrence BJ; Corti EJ; Booth L; Gasson N; Thomas MG; Loftus AM; Bucks RS
    J Parkinsons Dis; 2016 May; 6(3):609-16. PubMed ID: 27258699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Features of gut microbiota in patients with idiopathic Parkinson's disease].
    Li Y; Li RX; Du YT; Xu XJ; Xue Y; Gao D; Gao T; Sheng Z; Zhang LY; Tuo HZ
    Zhonghua Yi Xue Za Zhi; 2020 Apr; 100(13):1017-1022. PubMed ID: 32294860
    [No Abstract]   [Full Text] [Related]  

  • 18. Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson's disease patients.
    Bedarf JR; Hildebrand F; Coelho LP; Sunagawa S; Bahram M; Goeser F; Bork P; Wüllner U
    Genome Med; 2017 Apr; 9(1):39. PubMed ID: 28449715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Designing a new scale to measure anxiety symptoms in Parkinson's disease: item selection based on canonical correlation analysis.
    Martinez-Martin P; Rojo-Abuin JM; Dujardin K; Pontone GM; Weintraub D; Forjaz MJ; Starkstein S; Leentjens AF
    Eur J Neurol; 2013 Aug; 20(8):1198-203. PubMed ID: 23581431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anxiety in early Parkinson's disease: Validation of the Italian observer-rated version of the Parkinson Anxiety Scale (OR-PAS).
    Santangelo G; Falco F; D'Iorio A; Cuoco S; Raimo S; Amboni M; Pellecchia MT; Longo K; Vitale C; Barone P
    J Neurol Sci; 2016 Aug; 367():158-61. PubMed ID: 27423582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.